GEN-001

· Genome & Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GEN-001, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer [Phase 2]